Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Dabur India’s board of directors has approved increasing the investment limit for Foreign Institutional Investors (FIIs) from 24% to 30%.
“Currently, FIIs hold around 21% shares of the company, which is likely to exceed 24% very shortly. With increased participation by FIIs in the Indian capital market, we have decided to increase the FII investment limit to 30% for investment in company’s capital under the Portfolio Investment Scheme (PIS),” Dabur India Ltd Group Director P D Narang said in a statement.
The company would now be seeking its shareholders’ approval for the FII limit hike through a postal ballot. Established in 1884, Dabur India Limited is amongst the leading FMCG Companies in India with Revenues in excess of Rs 6,170 Crore. Dabur is the world’s leading Ayurvedic and Natural Health Care Company.
Dabur’s FMCG portfolio today includes Dabur as the master brand for natural healthcare products and Real for fruit juices and beverages along with three other renown brands – Vatika, Fem and Hajmola.
Dabur also has a significant presence in over 60 countries across the globe. Dabur’s overseas revenues account for over 30% of the total turnover.